NCT03274401 Screening for Atrial Fibrillation in Pulmonary Embolism Study -SAFE-PE Study Status TERMINATED Phase NA
NCT03273322 Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure Status COMPLETED Phase PHASE2/PHASE3
NCT03272620 Atrial Fibrillation at the Viennese University Emergency Department Status RECRUITING Phase N/A
NCT03269383 Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation Status WITHDRAWN Phase PHASE4
NCT03259373 IMplementation of an RCT to imProve Treatment With Oral AntiCoagulanTs in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT03258645 This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke Status COMPLETED Phase N/A
NCT03256812 ICT-based Monitoring for Arrhythmia Detection After AF Ablation Status COMPLETED Phase NA
NCT03254134 Comparative Effectiveness and Safety Between Warfarin and Dabigatran Status COMPLETED Phase N/A
NCT03247582 Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong) Status COMPLETED Phase N/A
NCT03247569 Edoxaban Treatment in Routine Clinical Practice for Patients With Non-Valvular Atrial Fibrillation (NVAF) Status COMPLETED Phase N/A
NCT03246594 Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation Status COMPLETED Phase NA
NCT03246568 Renal Nerve Denervation After Pulmonary Vein Isolation for Persistent Atrial Fibrillation Status TERMINATED Phase NA
NCT03243474 Non-invasive Monitoring for Early Detection of Atrial Fibrillation Status COMPLETED Phase N/A
NCT03242720 Effects of PAP on Afib Recurrence Risk After Catheter Ablation in OSA Patients Status WITHDRAWN Phase NA
NCT03242278 Real-world Dosing Patterns of Rivaroxaban in the United States Status COMPLETED Phase N/A